Bank of America
ODT

Bank of America’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Bank of America’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-118,871
Closed -$160K – 9155
2021
Q4 		$160K Buy
118,871
+101,100
+569% +$239K ﹤0.01% 6622
2021
Q3 		$51K Buy
17,771
+5,264
+42% +$17.5K ﹤0.01% 7040
2021
Q2 		$44K Sell
12,507
-5,631
-31% -$19.3K ﹤0.01% 6899
2021
Q1 		$62K Buy
18,138
+12,166
+204% +$230K ﹤0.01% 6564
2020
Q4 		$115K Buy
5,972
+631
+12% +$9.74K ﹤0.01% 5917
2020
Q3 		$71K Sell
5,341
-21,526
-80% -$610K ﹤0.01% 5854
2020
Q2 		$1.14M Buy
26,867
+132
+0.5% +$4.27K ﹤0.01% 4028
2020
Q1 		$737K Buy
26,735
+155
+0.6% +$4.52K ﹤0.01% 4216
2019
Q4 		$863K Sell
26,580
-6,690
-20% -$207K ﹤0.01% 4608
2019
Q3 		$867K Buy
33,270
+26,144
+367% +$875K ﹤0.01% 4655
2019
Q2 		$262K Buy
7,126
+3,726
+110% +$89.3K ﹤0.01% 5477
2019
Q1 		$76K Sell
3,400
-2,492
-42% -$43.6K ﹤0.01% 6019
2018
Q4 		$82K Buy
5,892
+4,216
+252% +$65.6K ﹤0.01% 6014
2018
Q3 		$32K Buy
1,676
+618
+58% +$12.6K ﹤0.01% 6371
2018
Q2 		$23K Buy
1,058
+468
+79% +$10.9K ﹤0.01% 6475
2018
Q1 		$13K Buy
+590
New +$13.9K ﹤0.01% 6533

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Bank of America's ODT Position: Q1 2022 in Review

Bank of America sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 118,871 shares — an estimated $160K sold.

Bank of America first reported a position in ODT in Q1 2018 and held it in 16 quarters. The position peaked at $1.14M in Q2 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • Bank of America reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 118,871 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $160K.
  • Bank of America first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • Bank of America's Odonate Therapeutics, Inc. Common Stock position peaked at $1.14M in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.